• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CDI BLOOD PARAMETER MONITORING SYSTEM 500; MONITOR, BLOOD-GAS, ON-LINE, CARDIOPULMONARY BYPASS-CDI BPM SYSTEM 500

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CDI BLOOD PARAMETER MONITORING SYSTEM 500; MONITOR, BLOOD-GAS, ON-LINE, CARDIOPULMONARY BYPASS-CDI BPM SYSTEM 500 Back to Search Results
Model Number 500AVHCT
Device Problem Improper Device Output (2953)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/29/2018
Event Type  malfunction  
Manufacturer Narrative
No consequences or impact to patient.Improper device output.Monitor.Evaluation is in progress, but not yet concluded.This complaint is related to (b)(4)/ medwatch #1828100-2018-00089.
 
Event Description
It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, there was an error with the ph measurement.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the patient.Per clinical review: on (b)(6) 2018, the clinicians calibrated the shunt sensor with both gas a and b for the procedure without concerns or errors.During the initial part of the bypass procedure, prior to the first in-vivo calibration, the ph value was reading 1.0 and the partial portion of oxygen (po2) was reading 100 mmhg.The values from the arterial blood gas (abg) are not known at this point for it was prior in-vivo calibration.The noted differences in the values were rectified after the first in-vivo calibration and the parameter values were consistently accurate the remainder of the procedure.There was no delay due to the perceived inaccuracies on the blood parameter monitoring (bpm).The team did not change the shunt sensor or the monitor during the procedure.There was no blood loss, nor harm associated with the incident.
 
Manufacturer Narrative
The reported complaint could not be confirmed.During laboratory analysis, the product surveillance technician (pst) was unable to verified the reported issue.The monitor was placed in its operate mode for 3 hours at ambient room temperature, arterial and venous blood parameter monitors (bpm) ph, carbon dioxide (co2), oxygen (o2), potassium (k+) and temperatures readings showed no anomalies or any erratic values and were stable.Monitor was placed in its service mode again and another bpm standard reference sensor test (srs) test on arterial and venous bpm's seven channels was performed and remained consistent with the previous testing, with service mode alert limit failures above the +20% to -30% limits set for drift.Monitor was restarted and again passed startup self-diagnostics.No accuracy is claimed before an in-vivo calibration is performed with the 1.69 software.The clinical review action item states that the clinicians acknowledged that after in-vivo calibration was performed the parameter values were consistently accurate the remainder of the procedure.The monitor operated as intended following in-vivo calibration; as per the instructions for use (ifu) states.Per central engineering, there was no claim of accuracy before in-vivo process had taken place.As a result, blood loop testing is not required.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CDI BLOOD PARAMETER MONITORING SYSTEM 500
Type of Device
MONITOR, BLOOD-GAS, ON-LINE, CARDIOPULMONARY BYPASS-CDI BPM SYSTEM 500
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
6200 jackson road
ann arbor MI 48103
Manufacturer Contact
eileen dorsey
6200 jackson road
ann arbor, MI 48103
7346634145
MDR Report Key7290208
MDR Text Key101012109
Report Number1828100-2018-00091
Device Sequence Number1
Product Code DRY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K123039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number500AVHCT
Device Catalogue Number500AVHCT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/15/2018
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/29/2018
Initial Date FDA Received02/22/2018
Supplement Dates Manufacturer Received04/03/2018
Supplement Dates FDA Received04/03/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/27/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Removal/Correction Number1828100-08/07/15-002-C
Patient Sequence Number1
-
-